Pharmaceutical preparations company · NV · FY ends Aug · Revenue $0.00
Revenue declined 100.0% YoY. The question is whether this is cyclical or a structural shift.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$0.00
▼ -100.0% YoY
Net Income (TTM)
-$368K
▲ +54.8% YoY
Op. Margin
—
ROIC
-1293.81%
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$159K
▲ +29.9% YoY
Net Debt
$63K
Cash & Equiv.
$12K
Continue Research